Laurel Wealth Advisors (North Carolina)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Buy |
5,397
+5,328
| +7,722% | +$68.1K | ﹤0.01% | 531 |
|
|
2025
Q1 | $5K | Hold |
69
| – | – | ﹤0.01% | 534 |
|
|
2024
Q4 | $5.11K | Hold |
69
| – | – | ﹤0.01% | 553 |
|
|
2024
Q3 | $4.55K | Hold |
69
| – | – | ﹤0.01% | 525 |
|
|
2024
Q2 | $6.37K | Hold |
69
| – | – | ﹤0.01% | 459 |
|
|
2024
Q1 | $6.59K | Hold |
69
| – | – | ﹤0.01% | 466 |
|
|
2023
Q4 | $5.26K | Hold |
69
| – | – | ﹤0.01% | 446 |
|
|
2023
Q3 | $4.78K | Hold |
69
| – | – | ﹤0.01% | 452 |
|
|
2023
Q2 | $6.51K | Hold |
69
| – | – | ﹤0.01% | 435 |
|
|
2023
Q1 | $5.71K | Hold |
69
| – | – | ﹤0.01% | 446 |
|
|
2022
Q4 | $5.15K | Hold |
69
| – | – | ﹤0.01% | 428 |
|
|
2022
Q3 | $6K | Hold |
69
| – | – | ﹤0.01% | 408 |
|
|
2022
Q2 | $7K | Hold |
69
| – | – | ﹤0.01% | 404 |
|
|
2022
Q1 | $8K | Hold |
69
| – | – | ﹤0.01% | 418 |
|
|
2021
Q4 | $9K | Sell |
69
-486
| -88% | -$63.4K | ﹤0.01% | 418 |
|
|
2021
Q3 | $63K | Hold |
555
| – | – | 0.01% | 252 |
|
|
2021
Q2 | $57K | Sell |
555
-69
| -11% | -$7.09K | 0.01% | 265 |
|
|
2021
Q1 | $52K | Hold |
624
| – | – | 0.01% | 265 |
|
|
2020
Q4 | $57K | Hold |
624
| – | – | 0.01% | 248 |
|
|
2020
Q3 | $50K | Hold |
624
| – | – | 0.01% | 237 |
|
|
2020
Q2 | $43K | Sell |
624
-69
| -10% | -$4.76K | 0.01% | 245 |
|
|
2020
Q1 | $44K | Buy |
693
+69
| +11% | +$4.38K | 0.02% | 232 |
|
|
2019
Q4 | $49K | Hold |
624
| – | – | 0.02% | 242 |
|
|
2019
Q3 | $46K | Buy |
624
+66
| +12% | +$4.87K | 0.02% | 243 |
|
|
2019
Q2 | $34K | Sell |
558
-66
| -11% | -$4.02K | 0.01% | 272 |
|
|
2019
Q1 | $40K | Hold |
624
| – | – | 0.01% | 247 |
|
|
2018
Q4 | $32K | Buy |
+624
| New | +$32K | 0.01% | 253 |
|